Cordycepin Inhibits LPS-induced Inflammatory and Matrix Degradation in the Intervertebral Disc

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2016 May 19

PMID 27190710

Citations 25

Authors

Yan Li

Kang Li

Lu Mao

Xiuguo Han

Kai Zhang

Changqing Zhao

Jie Zhao

Affiliations

Soon will be listed here.

Abstract

Cordycepin is a component of the extract obtained from Cordyceps militaris and has many biological activities, including anti-cancer, anti-metastatic and anti-inflammatory effects. Intervertebral disc degeneration (IDD) is a degenerative disease that is closely related to the inflammation of nucleus pulposus (NP) cells. The effect of cordycepin on NP cells in relation to inflammation and degeneration has not yet been studied. In our study, we used a rat NP cell culture and an intervertebral disc (IVD) organ culture model to examine the inhibitory effects of cordycepin on lipopolysaccharide (LPS)-induced gene expression and the production of matrix degradation enzymes (MMP-3, MMP-13, ADAMTS-4, and ADAMTS-5) and oxidative stress-associated factors (nitric oxide and PGE2). We found a protective effect of cordycepin on NP cells and IVDs against LPS-induced matrix degradation and macrophage infiltration. In addition, western blot and luciferase assay results demonstrated that pretreatment with cordycepin significantly suppressed the LPS-induced activation of the NF-κB pathway. Taken together, the results of our research suggest that cordycepin could exert anti-inflammatory and anti-degenerative effects on NP cells and IVDs by inhibiting the activation of the NF-κB pathway. Therefore, cordycepin may be a potential treatment for IDD in the future.

Citing Articles

Cordycepin attenuates NLRP3/Caspase-1/GSDMD-mediated LPS-induced macrophage pyroptosis.

Liu Z, Lv L, Wei J, Xie Y, Jili M, Huang Y Front Pharmacol. 2025; 16:1526616.

PMID: 40028157 PMC: 11868043. DOI: 10.3389/fphar.2025.1526616.

Role of macrophage in intervertebral disc degeneration.

Dou Y, Zhang Y, Liu Y, Sun X, Liu X, Li B Bone Res. 2025; 13(1):15.

PMID: 39848963 PMC: 11758090. DOI: 10.1038/s41413-024-00397-7.

The anti-oxidation related bioactive materials for intervertebral disc degeneration regeneration and repair.

Mai Y, Wu S, Zhang P, Chen N, Wu J, Wei F Bioact Mater. 2024; 45:19-40.

PMID: 39588482 PMC: 11585838. DOI: 10.1016/j.bioactmat.2024.10.012.

Characterization, Antioxidant Capacity and Protective Effect of Peptides from Cultivated with Tussah Pupa on Oxidative Injured HepG2 Cells.

Li B, Zhang J, Liu Y, Wang Z, Xu F J Microbiol Biotechnol. 2024; 34(5):1082-1091.

PMID: 38719776 PMC: 11180915. DOI: 10.4014/jmb.2312.12012.

Poly-3-hydroxybutyrate-co-3-hydroxyvalerate(PHBV)-Polyethylene glycol 20k(PEG20k) as a promising delivery system for PT2399 in the treatment of disc degeneration.

Li Z, Zhang W, Huang S, Dai Z, Liang J, Qiu Q J Biol Eng. 2024; 18(1):11.

PMID: 38254196 PMC: 10804636. DOI: 10.1186/s13036-024-00407-6.

References

Berenbaum F . Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol. 2004; 16(5):616-22. DOI: 10.1097/01.bor.0000133663.37352.4a. View

England S, Bevan S, Docherty R . PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol. 1996; 495 ( Pt 2):429-40. PMC: 1160802. DOI: 10.1113/jphysiol.1996.sp021604. View

Kim H, Naura A, Errami Y, Ju J, Boulares A . Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP. Mol Med. 2011; 17(9-10):893-900. PMC: 3188885. DOI: 10.2119/molmed.2011.00032. View

Nakamura K, Shinozuka K, Yoshikawa N . Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis. J Pharmacol Sci. 2015; 127(1):53-6. DOI: 10.1016/j.jphs.2014.09.001. View

Wang J, Tian Y, Phillips K, Chiverton N, Haddock G, Bunning R . Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Arthritis Rheum. 2012; 65(3):832-42. PMC: 3582738. DOI: 10.1002/art.37819. View

Rajan N, Bloom O, Maidhof R, Stetson N, Sherry B, Levine M . Toll-Like Receptor 4 (TLR4) expression and stimulation in a model of intervertebral disc inflammation and degeneration. Spine (Phila Pa 1976). 2012; 38(16):1343-51. DOI: 10.1097/BRS.0b013e31826b71f4. View

Walter B, Purmessur D, Likhitpanichkul M, Weinberg A, Cho S, Qureshi S . Inflammatory Kinetics and Efficacy of Anti-inflammatory Treatments on Human Nucleus Pulposus Cells. Spine (Phila Pa 1976). 2015; 40(13):955-63. PMC: 4567470. DOI: 10.1097/BRS.0000000000000932. View

Lee S, Kim T, Park J, Ra J . Inhibition of nitric oxide mediated protein nitration: therapeutic implications in experimental radiculopathy. Spine (Phila Pa 1976). 2013; 38(20):1749-53. DOI: 10.1097/BRS.0b013e3182a085d9. View

Imamura K, Asai M, Sugamoto K, Matsumoto T, Yamasaki Y, Kamei I . Suppressing effect of cordycepin on the lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells. Biosci Biotechnol Biochem. 2015; 79(6):1021-5. DOI: 10.1080/09168451.2015.1008977. View

10.

Wuertz K, Haglund L . Inflammatory mediators in intervertebral disk degeneration and discogenic pain. Global Spine J. 2014; 3(3):175-84. PMC: 3854585. DOI: 10.1055/s-0033-1347299. View

11.

Shi Z, Gu T, Xin H, Wu J, Xu C, Zhang C . Intervention of rAAV-hTERT-Transducted Nucleus Pulposus Cells in Early Stage of Intervertebral Disc Degeneration: A Study in Canine Model. Tissue Eng Part A. 2015; 21(15-16):2186-94. DOI: 10.1089/ten.TEA.2014.0408. View

12.

Jeong J, Jin C, Kim G, Lee J, Park C, Kim G . Anti-inflammatory effects of cordycepin via suppression of inflammatory mediators in BV2 microglial cells. Int Immunopharmacol. 2010; 10(12):1580-6. DOI: 10.1016/j.intimp.2010.09.011. View

13.

Yoshida M, Nakamura T, Kikuchi T, Takagi K, Matsukawa A . Expression of monocyte chemoattractant protein-1 in primary cultures of rabbit intervertebral disc cells. J Orthop Res. 2002; 20(6):1298-304. DOI: 10.1016/S0736-0266(02)00060-8. View

14.

Schwarzer A, Aprill C, Derby R, Fortin J, Kine G, Bogduk N . The relative contributions of the disc and zygapophyseal joint in chronic low back pain. Spine (Phila Pa 1976). 1994; 19(7):801-6. DOI: 10.1097/00007632-199404000-00013. View

15.

Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View

16.

Patel K, Sandy J, Akeda K, Miyamoto K, Chujo T, An H . Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration. Spine (Phila Pa 1976). 2007; 32(23):2596-603. DOI: 10.1097/BRS.0b013e318158cb85. View

17.

Tortorella M, Burn T, Pratta M, Abbaszade I, Hollis J, Liu R . Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science. 1999; 284(5420):1664-6. DOI: 10.1126/science.284.5420.1664. View

18.

Bachmeier B, Nerlich A, Mittermaier N, Weiler C, Lumenta C, Wuertz K . Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur Spine J. 2009; 18(11):1573-86. PMC: 2899407. DOI: 10.1007/s00586-009-1031-8. View

19.

Yang H, Cao C, Wu C, Yuan C, Gu Q, Shi Q . TGF-βl Suppresses Inflammation in Cell Therapy for Intervertebral Disc Degeneration. Sci Rep. 2015; 5:13254. PMC: 4542522. DOI: 10.1038/srep13254. View

20.

Le Maitre C, Freemont A, Hoyland J . Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 2004; 204(1):47-54. DOI: 10.1002/path.1608. View